Placements@ : accenture accutest Apcer Apollo artemis Aurobindo bioserve Bioxcel Chiltern Clinirx Cognizant Dabur Excel fortis-healthworld FreseniusKabi global_healthcity iCare icon intas Jubilant Max-Neeman Max Merck MMS MSD Novartis panaceaBiotech rajiv Ranbaxy Reliance ResMed Strides Syntel tcs torrent
Inside Cliniminds
Our Pharmacovigilance Training
Partner
Clinical Research News
Clinical Research News
- Kui ar
fdsfsdf....
- H1N1 shots from next week

NEW DELHI: Mass vaccination against the deadly H1N1 swine flu virus are likely to begin in India next week. The 1.5 million doses of vaccines imported by the government from Sanofi Pasteur have pas....

- Can an ibuprofen a day keep Parkinson’s away?

Parkinson’s is a neurodegenerative disease earlier believed to affect the elderly, but now seems to be striking Indians in their 40s and 50s, according to neurologists at the All India Instit....

- Albany Med joins national Alzheimer’s clinical trial

Albany Medical Center has been chosen to participate in a National Institutes of Aging clinical trial aimed at finding techniques to diagnose Alzheimer’s disease.The trial, which will take pl....

- New drug shows promise for advanced prostate cancer patients

New results from a phase II clinical trial of the prostate cancer drug abiraterone suggest that it may help men with advanced disease who have tried standard treatments.However, a Cancer Research U....

- J&J drug helps in last-ditch prostate cancer fight

The drug, which J&J took on after buying Cougar Biotechnology for about $970 million last year, has previously shown good results in men who did not receive chemotherapy.

The latest Pha....

- Phase-I human trials of H1N1 vaccine a success: SII

The Pune-based vaccine major Serum Institute of India (SII) on Friday announced the success of phase-I human clinical trials of its indigenous intra-nasal swine flu vaccine.

“As per ....

- Aspirin Benefit Seen in Established Breast Cancer

An aspirin at least two days a week significantly reduced breast cancer death risk by 64% to 71%, Michelle D. Holmes, MD, DrPH, of the Channing Laboratory at Harvard and Brigham and Women's Hospita....

- Drug trials begin for cancer, Alzheimer's

Integral Bio Sciences, a collaborative life sciences venture among scientists and investors from India and the US, has started the crucial 'phase four’ trials of original drug discovery to tr....

- Health Ministry begins process for upgradation of Clinical Trial Registry of India

Aiming to incorporate several new features as per the requirements of the World Health Organisation (WHO), the Union Health Ministry will soon upgrade the Clinical Trial Registry of India (CTRI) wh....

- Tougher law on human clinical research likely

“If any violations occur in trials here, the punishment should be as stringent as it is in other countries where these (multinational drug) companies do research,” he said. “Human....

- Clinical Research

New body to impart clinical training to doctors for HIV treatment

In an endeavour to formulate India-specific treatment guidelines for HIV patients, a group of medical prof....

Sep 21 2009 1 - Outsourcing clinical trials: Is it ethical to take drug studies abroad?

The average American income is $47,000 a year — 16 times what the average Indian takes home, according to the CIA World Factbook. There is one doctor for every 384 Americans, while there are ....

Sep 21 2009 1 - India would be among top 10 pharma markets by 2015: Report

Federation of Indian Chambers of Commerce and Industry (Ficci) with Ernst and Young (E&Y) forecasts big potential for multinational companies in the Indian Pharma segment, owing to a rise in hi....

Sep 21 2009 1 - Patented drugs market in India to touch $8 bn by 2015: Report

"The patent infrastructure in the country has been appreciably upgraded over the past few years to support new laws with the addition of patent examiners, de centralisation of the filing proce....

Sep 21 2009 1 - Pharma market in global top 10 by 2015: Report

The Indian pharmaceutical market will treble to $20 billion from $7.1 billion (2007 figure) by 2015, with a compounded annual growth rate (CAGR) of 12.3 per cent.

 

Link :

Sep 21 2009 1 - Pharma market may touch $20 billion by 2015

Besides, the report said the domestic pharma market is likely to touch $20 billion by 2015, making India a lucrative destination for clinical trials for global giants. Patent products may capture 8....

Sep 21 2009 1 - Indian pharma industry a lucrative destination for MNCs, to feature among global top 10 by 2015: Report

India's growing pharmaceutical industry is expected to touch $20 billion by 2015 and feature among the global top 10, a joint report published by the Federation of Indian Chambers of Commerce and I....

Sep 21 2009 1 - ndian pharma market to triple to $20 bln by 2015: Report

 trend is also evident in recent deals such as TCS-Roche for global capacity building, Accenture-BMS for a joint PV center in Chennai and the Cognizant-Astra Zeneca agreement for supporting gl....

Sep 21 2009 1 - Growing pharma market makes India a clinical trial destination: Report

By 2015 MNCs with patented drugs could account for $8 billion in the domestic pharmaceutical market, nearly 8-10 per cent of the total market.

 

Link :

Aug 27 2009 - Biocon mulls listing of two of its arms by next yr

Clinigene is a full-service Clinical Research Organization that services global pharmaceutical and biotechnology companies in their clinical development programs whereas Syngene is a contract resea....

Aug 26 2009 1 - Women more likely to die in 30 days after heart attack
The major cause of death from cardiovascular disease is acute coronary syndromes, the dangerous rupture of plaque inside the heart's coronary artery. Link : http://timesofindia.indiatimes.com/lif....
Aug 26 2009 1 - Disclosure of Financial Relationships to Participants in Clinical Research
The Institute of Medicine has recently stressed the need for vigilance in managing conflicts of interest to ensure the integrity of clinical research.5 The Institute of Medicine adopts a position si....
Aug 12 2009 - Cliniminds-Clinical Research Institute Announces Scholarship Program.

 

New Delhi, India, Monday, 20 JULY 2009- Cliniminds www.cliniminds.com - Cliniminds -Premier Clinical research Institute in India announced the....

Aug 8 2009 1 - India a preferred destination for clinical trials: Study
The cost advantage is luring many pharma companies to prefer India as the destination for contract research and clinical trials to the developed markets, a joint study by FICCI and E&Y said. Lin....
Aug 6 2009 - Schedule Y1 set to check fly-by-night operators in clinical trial sector

The Schedule Y1 Draft Rules, which are under scrutiny by the Clinical Research Organizations (CROs) in the country, have been broadly welcomed by most of them. Key provisions of the Rules namely 12....

Jul 3 2009 - Economic Survey calls for decontrol of drug prices

The Economic Survey has called for decontrolling of drug prices and limiting the checks only to essential drugs, which have less than five producers. "Drug price control should be limited....

Jun 29 2009 - Bringing more transparency to clinical trials

The Clinical Trial Registry — India ( www.ctri.in) is freely accessible to the public
About 300 trials are registered in the Indian registry; 150 trials ....

Jun 29 2009 - Now, all human clinical trials to be registered

In a significant move aimed at making clinical trials on human beings more ethical and transparent, the Drugs Controller of India has ruled for the first time that all clinical trials taking place ....

Jun 23 2009 - Swiss CRO moves into Indian clinical trials market

Switzerland-based contract research organisation PFC Pharma Focus has set up an Indian subsidiary with the help of Excel Life Sciences, a US firm that specialises in running trials in India.PFC Ind....

Jun 23 2009 - Union government to table Bill to check clinical trial violations by August

Union government is expected to finalise the Bill which will monitor unethical clinical trials in the country. The bill will police individuals and organizations engaged in the unscrupulous practic....

Jun 1 2009 - Aspirin may not benefit healthy people: Lancet

A new study published in the recent issue of The Lancet has revealed that aspirin is of “uncertain net value” in preventing heart attacks and strokes among healthy people (“primar....

Jun 1 2009 - Actis Biologics to commence phase-III clinical trial on colon cancer soon

Mumbai-based Actis Biologics Pvt Ltd, the biotech research and technology incubator company, is expecting approval to initiate phase-III studies of its potential anti-sense speciality product, Angi....

Jun 1 2009 - Sanofi-aventis spreading clinical research activities in India

Sanofi-aventis, the world's third largest French pharma giant, has decided to expand its clinical research activities in India with the help of its Indian subsidiary - Aventis Pharma Ltd. Currently....

May 12 2009 - Separate norms likely for drug trials on children, elderly, pregnant women

WITH a large number of clinical trials poised to move to India, the Health Ministry is planning to come up with separate protocols and norms for testing of new drugs on specialised population group....

May 12 2009 - Tighter norms for drug clinical trials

Bangalore, May 9 The country’s drug regulator plans to enforce mandatory registration and audit of CROs or clinical research organisations post-June this year. Details of the clinical trials ....

Apr 20 2009 - Powerful New IPhone App For Health Care Industry Allows Search Of All Registered Clinical Trials

Before today, searching for one of more than 71,500 clinical trials in the National Library of Medicine and National Institutes of Health database required a chair, computer, internet connection, a....

Apr 20 2009 - Mandatory registration of human clinical trials from June

In a move that will allow greater transparency in human clinical trials conducted in India, the registration of all such trials will be made mandatory starting in June. The trials will be registere....

Apr 15 2009 - Unethical clinical trials may invite painful penalty

The government plans to amend the Drugs & Cosmetics Act to slap up to 10 years’ imprisonment and cancellation of licence for  violating norms for testing drugs on humans in India, ag....

Apr 1 2009 - New diabetes drug approved without trial

A new drug to combat diabetes, which is administered orally and not injected, was given a marketing approval by the Drugs Controller General of India (DCGI) without being put through the mandatory ....

Apr 1 2009 - Human clinical trial of stem cell-based drug

The Drug Controller General of India (DCGI) has given its approval for conducting the first Indian human clinical trial of stem cell-based drug. It will try to address `acute myocardial infraction'....

Apr 1 2009 - Eli Lilly, Zydus Cadila enter drug development deal

This is the first major drug discovery deal in the past nine months by India’s drug companies, since Tata’s funded drug discovery firm Advinus Therapeutics signed a deal with Ortho-McNe....

Mar 12 2009 1 - Biocon Syngene Bristol-Myers Squibb open new R&D unit

The facility, set up by Biocon subsidiary Syngene International, will advance Bristol-Myers’ work in discovery and early drug development from initial hit to phase I and phase II clinical stu....

- Indian firm makes clinical trials of stem drug for heart disease

An Indian firm is starting clinical trials for an off-the-shelf stem cell treatment for heart attacks and arteries in the limb, the first of its kind in the country, local tabloid Mail Today said T....

- Gujarat to get zonal office of Drug Controller of India soon

Gujarat, the growing hub of pharmaceutical companies, manufacturing of medical devices and clinical research organisations, will soon get a zonal office of the Drug Controller of India.

Lin....

- ‘Pneumonia is still a deadly killer in India’

About 75 pediatricians from across the state brainstormed today to discuss the preventive measures to be taken to fight pneumonia which according to the UNICEF data claims more lives in children be....

- Bharat Biotech's rotavirus vaccine enters phase 3 of clinical trials

Mr Prasad told ET, "We plan to conduct most of the trials in India and are in the process of identifying the trial sites. SAS, a Delhi-based NGO will be helping us with the clinical trials, We....

- Insulin Trial Drug Brings Encouraging Results

The study conducted on 52,000 patients found that 53 per cent achieved a blood glucose (HbA1c) level of less than seven per cent, which was equivalent to the target set by the International Diabete....

- Wyeth clarifies on child's death during drug trial

It should be noted that there are no laws at present to penalize and monitor pharma companies, which have messed up or violated norms while conducting global clinicaltrials for testing drugs in Ind....

- Most trials conducted under strict FDA, European rules

India has been a preferred destination for clinical trials ever since pharmaceutical outsourcing picked up at the start of the decade. As the number of human trials increased, the country modified ....

- ICMR comes out strict draft norms on clinical trials

The draft guidelines come at a time when India pipped China to become Asia's most popular destination for conducting clinical trials. According to the Planning Commission, 139 new trials were outso....

- Law in offing to tighten regulation of clinical trials

The need for monitoring, auditing and legal provisions for those conducting clinical trials assumes significance with growth of domestic market, and the country emerging as a hub for clinical resea....

- Making the right choice

The clinical research industry in India is growing exponentially and a number of institutes have flourished to produce candidates to meet this heavy demand for tranined people. Usha Sharma tra....

- International Journal for Clinical Studies

Clinical Research India

The Need for Education & Traning

Read News

....
- USFDA sets up offices in India

NEW DELHI: Consumers in India and US can now benefit from the enhanced safety of food, drugs and medical devices as the US Food and Drug Administration has set up its offices in India.

Lin....

- Kendle opens second office in India

US-based contract research organisation (CRO) Kendle has opened a second office in western India, supplementing its existing operation in New Dehli.The new office is in Ahmedabad, Gujarat state. Ke....

- Pfizer may buy Wyeth for $60bn

Pfizer Inc's proposed acquisition of rival drug company Wyeth, if successful, will create a large entity in India, offering block-buster medicines, vaccines and healthcare brands, since both the co....

- Drugs regulator issues warning letters to Wyeth pharma, GVK

An audit by India’s drugs quality regulator has found a clinical trial sponsored by Wyeth Pharmaceutical Ltd and monitored by GVK Biosciences Pvt Ltd has violated protocol, standard operating....

- Time to focus on Good Clinical Practices - Need for more precautions in conducting Clinical TrialsTime to focus on Good Clinical Practices - Need for more precautions in cond

In current trend the Western countries are actually running out of patients for Phase II trials, which form a crucial phase of product development. As a result, Indian companies are increasingly un....

- Ranbaxy’s respiratory drug clinical trials begin

Ranbaxy Laboratories Ltd announced on Friday that it has initiated the first phase of clinical trials on a drug for respiratory inflammation. The drug is being developed as part of the research and....

- India – Most Economical Destination for Conducting Global Clinical Trials

Developing a new drug is getting costlier, with our research, “Booming Clinical Trials Market in India”, estimating the cost of developing a new drug at nearly US$ 1200 in 2008, with ne....

Jan 5 2009 - Time Bomb? The Clinical Trial ‘Gold Rush’ In India

 The race to test drugs in India, where costs are lower and patients are plentiful, is creating a vast cottage industry of doctors and contract research operators, but a dearth of oversight an....

Jan 5 2009 - India-US team finds therapy for pancreatic cancer

 A team of Indian and American scientists has found a new way of treating pancreatic cancer that kills nine in 10 of some 40,000 people diagnosed with the disease in the US each year.

....

Jan 5 2009 - Nine dream jobs for the Indian youth

Research: Clinical research and pharma companies are also wooing those who are of a research bent of mind. With domestic pharmaceutical companies investing more in research as well as clinical tria....

Jan 5 2009 - Cancer centre to run major trial for drug

Head and neck cancers are among the top 10 cancers in Singapore, with some 200 new cases every year. Without treatment, patients die within a year. Of those who receive the standard treatment of su....

Jan 2 2009 - Novo to launch anti-diabetes drug in India by 2010

Danish pharmaceutical company Novo Nordisk plans to launch its anti-diabetes drug Liraglutide in India by 2010. The company claims that the drug, which helps faster control of blood sugar levels, w....

Jan 2 2009 - Cancer vaccine kicks up controversy in India

According to the company, the vaccine launched in India can be given to women from age 10 to 26. The office of the Drug Controller General of India did not reply to questions on how the vaccine was....

Jan 2 2009 - FDA panel weighs whether to allow certain drugs to continue to be marketed for the treatment of asthma.

The Wall Street Journal (12/11, Dooren) reports, "A Food and Drug Administration (FDA) panel of medical experts is weighing whether to allow certain drugs to continue to be marketed for the tr....

Jan 2 2009 - India can deliver affordable innovation to the world

Indian companies are increasingly undertaking “rescue trials” which increase the patient recruitment to make up for the shortfall in other parts of the world. Thus, India is becoming th....

Dec 10 2008 - Anti-malaria shot may be reality in 4 yrs

Two separate trials of the promising candidate vaccine RTSS/AS on children as young as eight weeks old in Africa, have found that it reduced clinical malaria incidents by nearly 65%.

links....

Dec 3 2008 - Pharma's new prescription—hospitals?

Indian pharmaceutical companies, which have traditionally provided generics drugs and established a strong brand name, are now expanding their scope of operations to include discovery research and ....

Dec 3 2008 - Scrutiny Grows of Drug Trials Abroad

Western pharmaceutical companies are facing intensifying scrutiny over the conduct of clinical trials in developing countries -- an increasingly important source of patients to test new drugs and g....

Dec 3 2008 - Overseas Drug Company Clinical Trials Face More Scrutiny

Overseas health regulators are beginning to take a closer look at drug clinical trials conducted in their countries, following several well-publicized safety scandals, The Wall Street Journal repor....

Dec 3 2008 - GVK Biosciences Strengthens Focus on "Development" Services

GVK Biosciences Private Limited (GVK BIO), one of Asia's leading CROs, today announced the appointment of Dr. Shoibal Mukherjee to the position of Senior Vice President - Clinical Development.

....
Nov 27 2008 - Regulatory Changes In India

As part of its broader examination of the clinical research process within its borders, India’s drug regulator may consider changing the rules and regulations governing first-in-man studies o....

Nov 25 2008 - Current Scenario of Clinical Research in India-Need more Education and Training

India emerged as a global hub for clinical research. According to a report by Mc Kinsey the global Clinical trial outsourcing opportunity in India in the pharmaceutical industry is estimated to be ....

Nov 24 2008 - India's biotech sector set to thrive despite downturn

India is one of the top biotech hubs in the world and despite a slowing global economy, the sector is expected to not just survive, but thrive. India is also a favourite for investment ....

Nov 24 2008 - Huge growth in clinical trials in country: Official

"In 2005, around 100 clinical trials had been approved in the country by the Drugs Controller of India (DCI). In 2006, it increased to around 150 and to 240 in 2007. In the current year, aroun....

Nov 20 2008 - Recession not to hit clinical trials: CROs

ndian clinical research organisations (CROs) do not see any near-term impact of recession as large pharma customers such asAstraZeneca and Glaxo continue to send more work to India, where these tri....

Nov 20 2008 - Fisher BioPharma mulls additional unit in Guj

Fisher BioPharma, a part of the US-based Thermo Fisher Scientific Inc., is now mulling an additional unit at its upcoming clinical trials logistics management facility in the Pharma Special Economi....

Nov 20 2008 - Booming Clinical Trials Market in India

India has emerged as a strong base for clinical trials in recent times. Due to the multitude of benefits it offers, the country is fast growing as a centre for conducting clinical trials for many i....

Nov 19 2008 - Doctoring drugs-New medicines need to be monitored carefully for any adverse reaction

PV professionals can aspire to be employed in a variety of companies. “The opportunities lie in pharma companies, contract research organisations like Clini Rx, specialised PV companies and s....

Nov 17 2008 - Biocon to invest Rs 100 cr in R&D

Biotechnology major Biocon will be investing Rs 100 crore in the next fiscal in enhancing its Research and Development (R&D) to keep pace with increased orders from multi-national firms as lead....

Nov 12 2008 - ICON Opens Full Service Central Laboratory in India

"India has become a key region for global clinical trials, which has greatly boosted the demand for local laboratory testing within a global laboratory network," commented Bob Scott-Edwar....

Nov 8 2008 - US giant picks Ahmedabad over six other cities for its plant

When the world’s leading R&D equipment maker, supplier and services provider ThermoFisher Scientific Inc decided to set up Asias first clinical trial supplies manufacturing and distributi....

Nov 8 2008 - Patient Recruitment Begins in India for Phase 3 Diabetes Trial

Spherix Incorporated reported that patient recruitment for its Phase 3 clinical trial of its potential type 2 diabetes drug, Naturlose(R), has begun in India.Expectations for India are to provide m....

Nov 6 2008 - India has to create awareness about clinical trials: Experts

The multi-million dollar outsourced clinical trial business in India is going through a rough patch, as the Contract Research Organisations (CROs) are facing difficulties in recruitment of patients....

Nov 5 2008 - Online okay for clinical trials by 2013

In a bid to ease the process of clinical trial approvals, the government plans to introduce e-governance for clinical trials in by 2013.The move would enable companies from any part of the world to....

Nov 3 2008 - Drug regulator to reduce time for licence approvals

Drug manufacturing companies, which had to wait for up to nine months for various licences, can now look forward to much faster clearances. The drug quality regulator has expedited the process of c....

Oct 31 2008 - Drug discovery for neglected diseases

In recent years, public, private and philanthropic organizations worldwide have started to work together to discover and develop new medicines to treat neglected diseases. This month, we feature tw....

Oct 30 2008 - Govt mulls ways to fund early drug research

The Department of Pharmaceuticals may seek budgetary support to fund early stages of drug clinical trials. The research projects will be assigned to the seven National Institutes of Pharmaceutical ....

Oct 30 2008 - AMRI expands in India

The Albany, N.Y., drug discovery company has had operations in Aurangabad, India, for about two years. It has expanded a manufacturing facility in that city to include a multipurpose pilot plant th....

Oct 30 2008 - India can offer cost-effective clinical trials to Australia

Australia will need to look beyond the US and Europe to translate its expertise in basic research into inventing drugs in the current economic scenario and cost-effective India could fill the gap, ....

Oct 27 2008 - India Becoming Locus of Pharma Outsourcing, RNCOS Predicts 34% Growth

According to our research report, “Indian Healthcare - New Avenues for Growth”, India, driven by factors such as low cost, availability of a large and skilled workforce and improving he....

Oct 27 2008 - Clinical research has opened up new vistas of employment

India is a young country, and with the economy opening up, students have much more options as far as education and job avenues are concerned. Many students, therefore, look to study newer courses t....

Oct 27 2008 - Govt may make registration of clinical research cos mandatory

In a move to step up vigil on clinical research, the government may make it mandatory to register clinical research organisations (CROs) and clinical trials conducted by them. The move would also c....

Oct 25 2008 - HIV vaccine trial shows promise, moves forward

In August the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced that a second Phase I AIDS vaccine clinical trial in....

Oct 24 2008 - Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that it has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ....

Oct 23 2008 - World pharma contract manufacturing market "to be worth over $31B by 2012"

The report, from PricewaterhouseCoopers, forecasts that China and India will continue to spearhead the region’s growth while Singapore will maintain its position as a centre for research and ....

Oct 23 2008 - Maui cancer-trial access to improve

Okazaki said clinical trials are an important part of cancer care and advance the diagnosis, prevention and treatment of cancer. "Many new drugs are being developed fairly quickly and clinical....

Oct 23 2008 - U.S. panel urges more cancer research funding

The U.S. government needs to step up funding for cancer research, which has stagnated this decade, as part of an effort to make beating cancer a national priority, a presidential advisory panel sai....

Oct 22 2008 - MSD Pharma eyes slot among top five firms

MSD Pharmaceuticals, the wholly-owned subsidiary of US-based multinational drug company Merck, has chartered an ambitious growth plan to emerge as one of the top five pharmaceutical companies in In....

Oct 22 2008 - Glenmark sets up global R&D unit in UK

Glenmark Pharmaceuticals has set up a global clinical research and development (R&D) unit in the UK to aid its R&D pipeline and co-ordinate its global clinical studies being conducted in th....

Oct 21 2008 - Pharma industry growing rapidly: Ramadoss

India is fast emerging as a hub for biotech products and the pharma industry is growing rapidly as a result of the government's policy initiatives, Health Minister Anbumani Ramadoss said Monday.

Oct 19 2008 - Research identifies type of vaccine that holds promise in protecting against TB

Researchers are one step closer to finding a vaccine that better protects against tuberculosis. An investigational vaccine for TB tested at Saint Louis University appears likely to offer significan....

Oct 16 2008 - Zydus Cadila files IND application for cardiovascular drug

Zydus Cadila has filed an Investigational New Drug application with Drugs Controller General of India for ZYT 1, which is used to prevent heart attack and stroke.

 

Link : ....

Oct 16 2008 - Eli Lilly's Rajiv Gulati on Pharma's Prospects in India and China

India's huge potential pharmaceutical market and wealth of industry talent means it will be strategically critical for multinationals in the years ahead, notes Rajiv Gulati, director of India-China....

Oct 16 2008 - Ranbaxy achieves landmark in anti-malarial research, receives DCGI approval for Phase III clinical trials

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the Company has obtained approval from the Drug Controller General of India to initiate Phase III human clinical trials in India for its ....

Oct 16 2008 - Ranbaxy gets nod for anti-malaria drug trials

Pharmaceutical major Ranbaxy Laboratories on Thursday said it has received approval from Drug Controller General of India (DGCI) to initiate human clinical trials for its anti-malaria drug.

Oct 16 2008 - Trials ‘bring us closer to HIV vaccine’

The STEP AIDS vaccine trial halted last year when the vaccine did not protect volunteers from HIV infection was a setback but not a failed trial, experienced AIDS researchers said today.

Li....

Oct 15 2008 - Trials ‘bring us closer to HIV vaccine’

The STEP AIDS vaccine trial halted last year when the vaccine did not protect volunteers from HIV infection was a setback but not a failed trial, experienced AIDS researchers said today.

&n....

Oct 15 2008 - Web Site on Medical Research in Kids Launched

"Clinical studies are essential to improving our understanding of how to diagnose, prevent and treat disease -- as well as how to stay healthy -- and this is true of children as well as adults....

Oct 15 2008 - Clinical trials can save lives

Clinical trials are the most effective means to further understanding and treatment of breast cancer. According to the American Cancer Association, over 180,000 women will get breast cancer this ye....

Oct 15 2008 - Minister calls for strict norms on import and export of drugs

Calling for stringent regulations on the import and export of drugs and food items to meet the global competition, External Affairs Minister Pranab Mukherjee has said the items people consume shoul....

Oct 14 2008 - Aethlon Medical Announces Completion of Human Safety Study

Aethlon Medical, Inc. (OTCBB:AEMD) today announced the completion of a human safety study conducted at the Fortis Hospital in Delhi, India. The primary objective of the study was to evaluate the sa....

Oct 13 2008 - Indian Pharma Inc-An emerging global pharma hub:CII-KPMG

Poised to scale new heights and striving hard to establish itself on the global stage, the Indian pharma industry has huge challenges ahead. Setting the trends, opportunities and challenges for mak....

Oct 13 2008 - India is a growth story for us-Karl-Ludwig Kley, Chairman, Executive Board, Merck

India will be one of the key focus countries for us in future. For us, India is a long term growth story. In the next five years, we hope to earn revenues of around $675 million from India, which i....

Oct 13 2008 - India as a base for clinical trials

The investigational new drug (IND) filing process in the Indian regulatory system needs to change drastically to meet competitive challenges from China and Eastern Europe, geographies that are beco....

Oct 13 2008 - Ranbaxy seeks nod for human clinical trials for new drug

Ranbaxy Laboratories Ltd announced on Monday that it has submitted an Investigational New Drug (IND) application to the Drug Controller General of India seeking permission to initiate Phase-I human....

Oct 12 2008 - Read What Obama and McCain Have to Say About Health Care Plans

Lower drug costs by allowing the importation of safe medicines from other developed countries, increasing the use of generic drugs in public programs and taking on drug companies that block cheaper....

Oct 12 2008 - Quark Pharmaceuticals announces study on use of siRNA

Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that the journal Cancer Research....

Oct 12 2008 - Study finds latest genetic link to schizophrenia

An international study conducted on members of Indian castes, has found an important link between genetics and schizophrenia.

The research is a collaborative effort between the University ....

Oct 12 2008 - NeoBiocon and Abraxis BioScience Launch Abraxane for Treatment of Breast Cancer

"The launch of ABRAXANE in the UAE represents a major strategic step in our plan to provide safer and more effective cancer treatments on a global scale," said Patrick Soon-Shiong, M.D., ....

Oct 10 2008 - Drugs Controller to tighten norms for clinical research

The draft guidelines for CROs would be ready by the year-end and by end-2009, norms would be in place, he said. The Indian clinical research segment is currently valued at USD 200 million and growi....

Oct 9 2008 - Indo-Australian study identifies genetic region involved in schizophrenia risk

A study involving an Indian population has led to an important discovery in schizophrenia genetics.

 

Link  :  http....

Oct 7 2008 - Three Europeans Scientists Share Nobel in Medicine for Aids and Cervical Cancer

Three Europeans shared the Nobel Prize for Medicine for discovering viruses responsible for AIDS and cervical cancer. HIV the virus that causes AIDS was discovered by two French virologists, Dr. Fr....

Oct 6 2008 - India fertile ground for trials

A study by pharmaceutical business intelligence firm Cutting Edge Information found that a clinical trial costs pharmaceutical companies on average $125 million (£75.25 million) in America co....

Oct 5 2008 - Lilly and Jubilant team up in drug development JV

Lilly has set up a 50:50 joint venture with Jubilant in Bangalore that will see the two companies collaborate on the development of new drugs in oncology, metabolic disease, cardiovascular and diab....

Oct 4 2008 - Bringing global trials home

It’s a classic case of market opportunity aplenty. The global clinical trials business is worth an estimated $50 billion at present and the thinking among the Indian regulators about allowing....

Oct 3 2008 - Arch Pharmalabs becomes a leading API maker

Sixteen years ago, Ajit Kamath was an eager 22-year old who couldn’t wait to make his mark on the world. His fortunes may have taken him down a m
eandering road, but today, the 38-year o....

Oct 1 2008 - Govt puts clinical research approvals on fast lane

The government has begun speeding up approvals in the area of clinical research which is set to boom in India, say top industry sources. The clinical research industry in India is currently $200 mi....

Sep 30 2008 - Global clinical research is exploring India

The clinical research industry in India has been growing rapidly. During the last 3 years it has increased from Rs. 20 crores to Rs. 100 crores. According to a recent McKinsey report, by the year 2....

Sep 29 2008 - Fundamentals of Clinical Trials

Research studies in all fields of medicine are known as clinical trials. These studies are conducted with an eye to the future, in hopes of finding safer or more effective methods to screen for, pr....

Sep 29 2008 - Quintiles’ Singapore Operations to Double in 2009

Contract-research organization (CRO) Quintiles is doubling the size of its Singapore operations, an expansion that will produce Asia-Pacific’s largest clinical development organization, accor....

Sep 29 2008 - Satyam and Oracle partner on clinical development applications

Indian IT services provider Satyam Computer Services has partnered with Oracle's new Health Sciences Global Business Unit to provide leading clinical development applications.

Link:  ....

Sep 29 2008 - HP Selects Kayentis as Solutions Business Partner for the Healthcare and Life Science Industries

Hewlett-Packard selects Kayentis, a global leader of Digital Pen and Paper technology, as Worldwide Solutions Business Partner for the Healthcare and Life Science industries.

Philadelphia,....

Sep 28 2008 - Encorium Announces the Initiation of a Strategic Partnership With Prologue Research

After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investigated

Link:&n....

Sep 28 2008 - Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval

 NEW YORK, Sept 25, 2008 /PRNewswire-USNewswire via COMTEX/ -- Total Value of the Commitment to the CGI is an Estimated $210 Million


Crofelemer, Once Approved for Children, Could....

Sep 27 2008 - Xcelris Labs in alliance with DMRI to provide BA/BE

Xcelris Labs, an Ahmedabad based CRO (Contract Research Organisation) set up by promoters of Claris Lifesciences Ltd., today announced, that it has entered into a Strategic Alliance agreement with ....

Jul 24 2008 - Biocon...A million destinies written.

Not content to be a star in generics, Mazumdar-Shaw now has 600 scientists doing research to develop the company's own patented drugs. Biocon has two compounds in

Jul 24 2008 - Genzyme Reports Strong Second-Quarter Growth

Genzyme announced plans for a research and development center in China and also began building a commercial organization in India , initiatives that....

May 14 2008 - Synchron scores first buyout in Indian CRO market

OutSourcing-Pharma.com - Montpellier,France
Parexel should be rubbing its hands at the news as the US-based CRO owns a majority stake in Synchron's Bangalore clinical trial business operations....

+91-9910068241
+91-9560102589
+91-9810068241
Google Reviews

divjot kaur
Stars I am a BDS Graduate and joined Post Graduate diploma in Pharmacovigilance and Clinical research from Cliniminds and got selected in Paraxel International ...more

K Soujanya
Stars Hi This is Soujanya.I did my MSc Biotechnology and Then joined Cliniminds for Advanced PG in CDM CR & SAS.The study material they provide is very useful for ...more
Placement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement TestimonialsPlacement Testimonials
   
Certificate of Accreditation
Accreditation
InternationalAccreditation
InternationalAccreditation
InternationalAccreditation
InternationalAccreditation
InternationalAccreditation
Dr. Subodh Bhardwaj
MD (Pharmacology) - Director of Health Sciences Education & Training
A innovative Medical Doctor with post - graduation in Pharmacology and more than 30+ years of experience in
Clinical Medicine, Clinical Research, Pharmacovigilance and Drug Regulatory Affairs.Read More...
FOLLOW Linkedin
facebook
Google+
Youtube
Blog